“…Subsequently, the risk stratification strength of the QRS-T angle has been confirmed in a large number of studies including investigations of other ischaemic heart disease populations ( de Torbal et al, 2004 ; Malik et al, 2004 ), acute coronary syndrome ( Lown et al, 2012 ), heart failure ( Gotsman et al, 2013 ; Selvaraj et al, 2014 ; Sweda et al, 2020 ), hypertrophic ( Cortez et al, 2017a ; Cortez et al, 2017b ; Jensen et al, 2021 ) and dilated cardiomyopathy ( Li et al, 2016 ), diabetic patients ( Voulgari et al, 2010 ; Cardoso et al, 2013 ; May et al, 2017 ; May et al, 2018 ), renal patients on haemodialysis ( de Bie et al, 2013 ; Poulikakos et al, 2018 ); and many other populations and conditions ranging from systemic sclerosis ( Gialafos et al, 2012 ) and Chagas disease ( Zampa et al, 2014 ) to overall hospital ( Yamazaki et al, 2005 ) and general populations ( Kardys et al, 2003 ; Kors et al, 2003 ; Walsh et al, 2013 ). It has also recently been shown that QRS-T angle might be meaningfully combined with other ECG-based risk factors ( Hnatkova et al, 2022 ).…”